Nuvation Bio Inc. (NUVB) short interest & options flow
NYSENUVB heads into the final days of September with a sharp contradiction at its core: short sellers have added aggressively to positions over the past week, yet the analyst community just received a fresh endorsement from Citigroup, and options traders are notably less defensive than they have been all month. Short interest is the dominant story this week. Shorts rebuilt…
- Market cap
- $1.47B
- Next earnings
- 4 Mar 2027
Key data as of 7 Nov 2026

NUVB news and analysis
RSSNo long-form analysis yet for NUVB. Pulse alerts and the live data picture are available on ORTEX.
Open NUVB on ORTEX →Want the live picture for NUVB?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for NUVB — free to start on ORTEX.
Sign up for free →Open NUVB on ORTEX